NTC
BEAT

North Tide Capital’s BioTelemetry, Inc. BEAT Stock Holding History

North Tide Capital’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-105,000
Closed -$620K – 31
2013
Q2 		$620K Buy
+105,000
New +$353K 0.11% 23

Other funds holding BEAT

CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

North Tide Capital's BEAT Position: Q3 2013 in Review

North Tide Capital sold out of BioTelemetry, Inc. (BEAT) in Q3 2013, closing a stake of 105,000 shares — an estimated $620K sold.

North Tide Capital first reported a position in BEAT in Q2 2013 and held it in 1 quarter. The position peaked at $620K in Q2 2013. 75 funds tracked by Wall St. Rank hold BEAT as of Q3 2013.

  • North Tide Capital reported no remaining BioTelemetry, Inc. position as of Q3 2013 after selling out during the quarter.
  • North Tide Capital sold 105,000 BioTelemetry, Inc. shares in Q3 2013, an estimated $620K.
  • North Tide Capital first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 1 quarter.
  • North Tide Capital's BioTelemetry, Inc. position peaked at $620K in Q2 2013.
  • 75 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2013.

Based on North Tide Capital's 13F filing for Q3 2013, filed 14 Nov 2013.